nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—ABCB1—colon cancer	0.539	1	CbGaD
Trifluoperazine—Megacolon—Irinotecan—colon cancer	0.0108	0.0695	CcSEcCtD
Trifluoperazine—HTR2A—myenteric nerve plexus—colon cancer	0.00921	0.0514	CbGeAlD
Trifluoperazine—EBPL—epithelium—colon cancer	0.00665	0.0371	CbGeAlD
Trifluoperazine—S100A4—embryo—colon cancer	0.00643	0.0359	CbGeAlD
Trifluoperazine—HTR2A—vein—colon cancer	0.00593	0.0331	CbGeAlD
Trifluoperazine—Megacolon—Methotrexate—colon cancer	0.00537	0.0346	CcSEcCtD
Trifluoperazine—S100A4—epithelium—colon cancer	0.00525	0.0293	CbGeAlD
Trifluoperazine—S100A4—smooth muscle tissue—colon cancer	0.00506	0.0283	CbGeAlD
Trifluoperazine—S100A4—renal system—colon cancer	0.00487	0.0272	CbGeAlD
Trifluoperazine—UGT1A4—renal system—colon cancer	0.00428	0.0239	CbGeAlD
Trifluoperazine—Miosis—Irinotecan—colon cancer	0.00423	0.0273	CcSEcCtD
Trifluoperazine—Ileus paralytic—Vincristine—colon cancer	0.0042	0.0271	CcSEcCtD
Trifluoperazine—S100A4—lymphoid tissue—colon cancer	0.00404	0.0226	CbGeAlD
Trifluoperazine—S100A4—digestive system—colon cancer	0.00399	0.0223	CbGeAlD
Trifluoperazine—EBPL—liver—colon cancer	0.00377	0.021	CbGeAlD
Trifluoperazine—Parkinsonism—Fluorouracil—colon cancer	0.00373	0.024	CcSEcCtD
Trifluoperazine—S100A4—bone marrow—colon cancer	0.00368	0.0206	CbGeAlD
Trifluoperazine—EBP—liver—colon cancer	0.00361	0.0202	CbGeAlD
Trifluoperazine—Pigmentation disorder—Capecitabine—colon cancer	0.00355	0.0229	CcSEcCtD
Trifluoperazine—Trismus—Capecitabine—colon cancer	0.00355	0.0229	CcSEcCtD
Trifluoperazine—S100A4—vagina—colon cancer	0.00353	0.0197	CbGeAlD
Trifluoperazine—UGT1A4—digestive system—colon cancer	0.00351	0.0196	CbGeAlD
Trifluoperazine—Sudden death—Irinotecan—colon cancer	0.00346	0.0223	CcSEcCtD
Trifluoperazine—CALM2—endothelium—colon cancer	0.00337	0.0188	CbGeAlD
Trifluoperazine—CALM1—endothelium—colon cancer	0.00335	0.0187	CbGeAlD
Trifluoperazine—Sudden death—Fluorouracil—colon cancer	0.00331	0.0213	CcSEcCtD
Trifluoperazine—Akathisia—Irinotecan—colon cancer	0.00319	0.0206	CcSEcCtD
Trifluoperazine—XDH—renal system—colon cancer	0.00312	0.0174	CbGeAlD
Trifluoperazine—CALM2—blood vessel—colon cancer	0.00311	0.0173	CbGeAlD
Trifluoperazine—CALM1—blood vessel—colon cancer	0.00309	0.0173	CbGeAlD
Trifluoperazine—S100A4—liver—colon cancer	0.00298	0.0166	CbGeAlD
Trifluoperazine—CALM2—gall bladder—colon cancer	0.00292	0.0163	CbGeAlD
Trifluoperazine—EBPL—lymph node—colon cancer	0.00289	0.0161	CbGeAlD
Trifluoperazine—Ileus paralytic—Capecitabine—colon cancer	0.00274	0.0177	CcSEcCtD
Trifluoperazine—CALY—lymph node—colon cancer	0.00264	0.0148	CbGeAlD
Trifluoperazine—UGT1A4—liver—colon cancer	0.00261	0.0146	CbGeAlD
Trifluoperazine—Ileus—Vincristine—colon cancer	0.00257	0.0165	CcSEcCtD
Trifluoperazine—XDH—digestive system—colon cancer	0.00256	0.0143	CbGeAlD
Trifluoperazine—Ileus—Irinotecan—colon cancer	0.0025	0.0161	CcSEcCtD
Trifluoperazine—Retinal disorder—Methotrexate—colon cancer	0.00247	0.0159	CcSEcCtD
Trifluoperazine—Sudden death—Capecitabine—colon cancer	0.00231	0.0149	CcSEcCtD
Trifluoperazine—S100A4—lymph node—colon cancer	0.00228	0.0127	CbGeAlD
Trifluoperazine—XDH—vagina—colon cancer	0.00226	0.0126	CbGeAlD
Trifluoperazine—HTR2A—endothelium—colon cancer	0.00204	0.0114	CbGeAlD
Trifluoperazine—TNNC1—lymph node—colon cancer	0.00192	0.0107	CbGeAlD
Trifluoperazine—XDH—liver—colon cancer	0.00191	0.0106	CbGeAlD
Trifluoperazine—HTR2A—blood vessel—colon cancer	0.00188	0.0105	CbGeAlD
Trifluoperazine—Gait disturbance—Vincristine—colon cancer	0.00186	0.012	CcSEcCtD
Trifluoperazine—CALM3—smooth muscle tissue—colon cancer	0.00185	0.0104	CbGeAlD
Trifluoperazine—CALM2—embryo—colon cancer	0.00185	0.0103	CbGeAlD
Trifluoperazine—CALM1—embryo—colon cancer	0.00184	0.0103	CbGeAlD
Trifluoperazine—Gait disturbance—Irinotecan—colon cancer	0.00181	0.0117	CcSEcCtD
Trifluoperazine—Sudden death—Methotrexate—colon cancer	0.00172	0.0111	CcSEcCtD
Trifluoperazine—Torsade de pointes—Capecitabine—colon cancer	0.00169	0.0109	CcSEcCtD
Trifluoperazine—Ileus—Capecitabine—colon cancer	0.00167	0.0108	CcSEcCtD
Trifluoperazine—SIGMAR1—smooth muscle tissue—colon cancer	0.00166	0.00926	CbGeAlD
Trifluoperazine—CALM2—epithelium—colon cancer	0.00151	0.00844	CbGeAlD
Trifluoperazine—CALM1—epithelium—colon cancer	0.0015	0.0084	CbGeAlD
Trifluoperazine—Antrafenine—PTGS2—colon cancer	0.00148	0.324	CrCbGaD
Trifluoperazine—CALM2—smooth muscle tissue—colon cancer	0.00146	0.00813	CbGeAlD
Trifluoperazine—CALM1—smooth muscle tissue—colon cancer	0.00145	0.00809	CbGeAlD
Trifluoperazine—HTR1A—renal system—colon cancer	0.00143	0.00797	CbGeAlD
Trifluoperazine—ADRA1A—epithelium—colon cancer	0.00142	0.00792	CbGeAlD
Trifluoperazine—CALM2—renal system—colon cancer	0.0014	0.00783	CbGeAlD
Trifluoperazine—Photosensitivity—Fluorouracil—colon cancer	0.0014	0.00903	CcSEcCtD
Trifluoperazine—CALM1—renal system—colon cancer	0.0014	0.00779	CbGeAlD
Trifluoperazine—Dermatitis exfoliative—Irinotecan—colon cancer	0.00136	0.00877	CcSEcCtD
Trifluoperazine—CALM3—bone marrow—colon cancer	0.00135	0.00754	CbGeAlD
Trifluoperazine—Anaphylactoid reaction—Irinotecan—colon cancer	0.00133	0.00855	CcSEcCtD
Trifluoperazine—ADRA1A—renal system—colon cancer	0.00131	0.00734	CbGeAlD
Trifluoperazine—CALM3—vagina—colon cancer	0.00129	0.00722	CbGeAlD
Trifluoperazine—Urinary retention—Vincristine—colon cancer	0.00125	0.00808	CcSEcCtD
Trifluoperazine—Cardiac arrest—Vincristine—colon cancer	0.00125	0.00808	CcSEcCtD
Trifluoperazine—ABCB1—blood vessel—colon cancer	0.00123	0.00689	CbGeAlD
Trifluoperazine—Cardiac arrest—Irinotecan—colon cancer	0.00122	0.00787	CcSEcCtD
Trifluoperazine—Gait disturbance—Capecitabine—colon cancer	0.00121	0.00782	CcSEcCtD
Trifluoperazine—SIGMAR1—bone marrow—colon cancer	0.00121	0.00674	CbGeAlD
Trifluoperazine—Cardiac arrest—Fluorouracil—colon cancer	0.00117	0.00754	CcSEcCtD
Trifluoperazine—CALM2—lymphoid tissue—colon cancer	0.00116	0.0065	CbGeAlD
Trifluoperazine—Muscular weakness—Vincristine—colon cancer	0.00116	0.0075	CcSEcCtD
Trifluoperazine—CALM1—lymphoid tissue—colon cancer	0.00116	0.00647	CbGeAlD
Trifluoperazine—SIGMAR1—vagina—colon cancer	0.00116	0.00645	CbGeAlD
Trifluoperazine—CALM2—digestive system—colon cancer	0.00115	0.00642	CbGeAlD
Trifluoperazine—CALM1—digestive system—colon cancer	0.00114	0.00639	CbGeAlD
Trifluoperazine—HTR2A—embryo—colon cancer	0.00112	0.00627	CbGeAlD
Trifluoperazine—HRH1—epithelium—colon cancer	0.0011	0.00613	CbGeAlD
Trifluoperazine—ADRA1A—lymphoid tissue—colon cancer	0.00109	0.0061	CbGeAlD
Trifluoperazine—CALM3—liver—colon cancer	0.00109	0.00609	CbGeAlD
Trifluoperazine—CYP1A2—renal system—colon cancer	0.00109	0.00607	CbGeAlD
Trifluoperazine—Muscular weakness—Fluorouracil—colon cancer	0.00108	0.00699	CcSEcCtD
Trifluoperazine—Pancytopenia—Vincristine—colon cancer	0.00108	0.00698	CcSEcCtD
Trifluoperazine—Dysphagia—Fluorouracil—colon cancer	0.00106	0.00685	CcSEcCtD
Trifluoperazine—CALM2—bone marrow—colon cancer	0.00106	0.00592	CbGeAlD
Trifluoperazine—HRH1—smooth muscle tissue—colon cancer	0.00106	0.0059	CbGeAlD
Trifluoperazine—CALM1—bone marrow—colon cancer	0.00106	0.00589	CbGeAlD
Trifluoperazine—Eosinophilia—Fluorouracil—colon cancer	0.00105	0.00679	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Vincristine—colon cancer	0.00105	0.00677	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Vincristine—colon cancer	0.00104	0.00671	CcSEcCtD
Trifluoperazine—CALM2—vagina—colon cancer	0.00102	0.00567	CbGeAlD
Trifluoperazine—CALM1—vagina—colon cancer	0.00101	0.00564	CbGeAlD
Trifluoperazine—Pancytopenia—Fluorouracil—colon cancer	0.00101	0.00651	CcSEcCtD
Trifluoperazine—Photosensitivity—Capecitabine—colon cancer	0.000978	0.00631	CcSEcCtD
Trifluoperazine—SIGMAR1—liver—colon cancer	0.000975	0.00544	CbGeAlD
Trifluoperazine—Photosensitivity reaction—Fluorouracil—colon cancer	0.00097	0.00626	CcSEcCtD
Trifluoperazine—Jaundice—Irinotecan—colon cancer	0.000964	0.00622	CcSEcCtD
Trifluoperazine—Haemolytic anaemia—Capecitabine—colon cancer	0.000952	0.00614	CcSEcCtD
Trifluoperazine—HTR2A—epithelium—colon cancer	0.000917	0.00512	CbGeAlD
Trifluoperazine—Increased appetite—Capecitabine—colon cancer	0.000914	0.0059	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Capecitabine—colon cancer	0.00091	0.00587	CcSEcCtD
Trifluoperazine—CYP1A2—digestive system—colon cancer	0.000892	0.00498	CbGeAlD
Trifluoperazine—Agranulocytosis—Fluorouracil—colon cancer	0.000884	0.0057	CcSEcCtD
Trifluoperazine—HTR2A—smooth muscle tissue—colon cancer	0.000883	0.00493	CbGeAlD
Trifluoperazine—CALM2—liver—colon cancer	0.000857	0.00478	CbGeAlD
Trifluoperazine—CALM1—liver—colon cancer	0.000853	0.00476	CbGeAlD
Trifluoperazine—HTR2A—renal system—colon cancer	0.00085	0.00475	CbGeAlD
Trifluoperazine—CALM3—lymph node—colon cancer	0.000836	0.00467	CbGeAlD
Trifluoperazine—HRH1—digestive system—colon cancer	0.000835	0.00466	CbGeAlD
Trifluoperazine—Aplastic anaemia—Methotrexate—colon cancer	0.000827	0.00534	CcSEcCtD
Trifluoperazine—Cardiac arrest—Capecitabine—colon cancer	0.000817	0.00527	CcSEcCtD
Trifluoperazine—Urinary retention—Capecitabine—colon cancer	0.000817	0.00527	CcSEcCtD
Trifluoperazine—ADRA1A—liver—colon cancer	0.000804	0.00449	CbGeAlD
Trifluoperazine—Gynaecomastia—Methotrexate—colon cancer	0.000788	0.00508	CcSEcCtD
Trifluoperazine—Muscular weakness—Capecitabine—colon cancer	0.000758	0.00489	CcSEcCtD
Trifluoperazine—SIGMAR1—lymph node—colon cancer	0.000748	0.00417	CbGeAlD
Trifluoperazine—Muscle spasms—Irinotecan—colon cancer	0.000743	0.00479	CcSEcCtD
Trifluoperazine—Asthma—Capecitabine—colon cancer	0.000743	0.00479	CcSEcCtD
Trifluoperazine—Dysphagia—Capecitabine—colon cancer	0.000743	0.00479	CcSEcCtD
Trifluoperazine—Erythema—Fluorouracil—colon cancer	0.00074	0.00478	CcSEcCtD
Trifluoperazine—HRH1—vagina—colon cancer	0.000737	0.00412	CbGeAlD
Trifluoperazine—ABCB1—embryo—colon cancer	0.000736	0.00411	CbGeAlD
Trifluoperazine—Bronchospasm—Capecitabine—colon cancer	0.00073	0.00471	CcSEcCtD
Trifluoperazine—Agitation—Vincristine—colon cancer	0.000729	0.0047	CcSEcCtD
Trifluoperazine—Photosensitivity—Methotrexate—colon cancer	0.000728	0.0047	CcSEcCtD
Trifluoperazine—Leukopenia—Vincristine—colon cancer	0.000711	0.00458	CcSEcCtD
Trifluoperazine—Pancytopenia—Capecitabine—colon cancer	0.000705	0.00455	CcSEcCtD
Trifluoperazine—Vision blurred—Fluorouracil—colon cancer	0.000698	0.0045	CcSEcCtD
Trifluoperazine—HTR2A—digestive system—colon cancer	0.000697	0.00389	CbGeAlD
Trifluoperazine—Leukopenia—Irinotecan—colon cancer	0.000692	0.00446	CcSEcCtD
Trifluoperazine—Convulsion—Vincristine—colon cancer	0.000688	0.00444	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Methotrexate—colon cancer	0.000678	0.00437	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Capecitabine—colon cancer	0.000678	0.00437	CcSEcCtD
Trifluoperazine—Weight increased—Capecitabine—colon cancer	0.000676	0.00436	CcSEcCtD
Trifluoperazine—Cough—Irinotecan—colon cancer	0.000675	0.00435	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Capecitabine—colon cancer	0.00067	0.00432	CcSEcCtD
Trifluoperazine—Flupentixol—ABCB1—colon cancer	0.000667	0.146	CrCbGaD
Trifluoperazine—CYP1A2—liver—colon cancer	0.000664	0.00371	CbGeAlD
Trifluoperazine—Leukopenia—Fluorouracil—colon cancer	0.000663	0.00427	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Methotrexate—colon cancer	0.000661	0.00426	CcSEcCtD
Trifluoperazine—CALM2—lymph node—colon cancer	0.000657	0.00367	CbGeAlD
Trifluoperazine—CALM1—lymph node—colon cancer	0.000654	0.00365	CbGeAlD
Trifluoperazine—Anaphylactic shock—Vincristine—colon cancer	0.000648	0.00418	CcSEcCtD
Trifluoperazine—Jaundice—Capecitabine—colon cancer	0.000645	0.00416	CcSEcCtD
Trifluoperazine—Convulsion—Fluorouracil—colon cancer	0.000641	0.00414	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Irinotecan—colon cancer	0.000631	0.00407	CcSEcCtD
Trifluoperazine—Agranulocytosis—Capecitabine—colon cancer	0.000618	0.00398	CcSEcCtD
Trifluoperazine—Anorexia—Vincristine—colon cancer	0.000618	0.00398	CcSEcCtD
Trifluoperazine—HTR2A—vagina—colon cancer	0.000616	0.00344	CbGeAlD
Trifluoperazine—Hypotension—Vincristine—colon cancer	0.000605	0.0039	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Fluorouracil—colon cancer	0.000604	0.0039	CcSEcCtD
Trifluoperazine—Anorexia—Irinotecan—colon cancer	0.000601	0.00388	CcSEcCtD
Trifluoperazine—ABCB1—epithelium—colon cancer	0.000601	0.00335	CbGeAlD
Trifluoperazine—Hypotension—Irinotecan—colon cancer	0.00059	0.0038	CcSEcCtD
Trifluoperazine—Insomnia—Vincristine—colon cancer	0.000586	0.00378	CcSEcCtD
Trifluoperazine—Oedema peripheral—Capecitabine—colon cancer	0.000585	0.00378	CcSEcCtD
Trifluoperazine—Anorexia—Fluorouracil—colon cancer	0.000576	0.00371	CcSEcCtD
Trifluoperazine—Insomnia—Irinotecan—colon cancer	0.000571	0.00368	CcSEcCtD
Trifluoperazine—Hypotension—Fluorouracil—colon cancer	0.000565	0.00364	CcSEcCtD
Trifluoperazine—Decreased appetite—Vincristine—colon cancer	0.000563	0.00363	CcSEcCtD
Trifluoperazine—Dyspnoea—Irinotecan—colon cancer	0.000562	0.00363	CcSEcCtD
Trifluoperazine—Somnolence—Irinotecan—colon cancer	0.000561	0.00362	CcSEcCtD
Trifluoperazine—Fatigue—Vincristine—colon cancer	0.000559	0.0036	CcSEcCtD
Trifluoperazine—ABCB1—renal system—colon cancer	0.000557	0.00311	CbGeAlD
Trifluoperazine—Constipation—Vincristine—colon cancer	0.000554	0.00357	CcSEcCtD
Trifluoperazine—Asthma—Methotrexate—colon cancer	0.000553	0.00357	CcSEcCtD
Trifluoperazine—Decreased appetite—Irinotecan—colon cancer	0.000548	0.00354	CcSEcCtD
Trifluoperazine—Eosinophilia—Methotrexate—colon cancer	0.000547	0.00353	CcSEcCtD
Trifluoperazine—Insomnia—Fluorouracil—colon cancer	0.000547	0.00352	CcSEcCtD
Trifluoperazine—Fatigue—Irinotecan—colon cancer	0.000544	0.00351	CcSEcCtD
Trifluoperazine—Constipation—Irinotecan—colon cancer	0.00054	0.00348	CcSEcCtD
Trifluoperazine—Dyspnoea—Fluorouracil—colon cancer	0.000539	0.00347	CcSEcCtD
Trifluoperazine—Somnolence—Fluorouracil—colon cancer	0.000537	0.00346	CcSEcCtD
Trifluoperazine—Decreased appetite—Fluorouracil—colon cancer	0.000525	0.00339	CcSEcCtD
Trifluoperazine—Pancytopenia—Methotrexate—colon cancer	0.000525	0.00339	CcSEcCtD
Trifluoperazine—HTR2A—liver—colon cancer	0.000519	0.0029	CbGeAlD
Trifluoperazine—Erythema—Capecitabine—colon cancer	0.000517	0.00334	CcSEcCtD
Trifluoperazine—Body temperature increased—Vincristine—colon cancer	0.000512	0.0033	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Methotrexate—colon cancer	0.000509	0.00328	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Methotrexate—colon cancer	0.000505	0.00325	CcSEcCtD
Trifluoperazine—Body temperature increased—Irinotecan—colon cancer	0.000499	0.00322	CcSEcCtD
Trifluoperazine—Muscle spasms—Capecitabine—colon cancer	0.000497	0.00321	CcSEcCtD
Trifluoperazine—Drowsiness—Methotrexate—colon cancer	0.000493	0.00318	CcSEcCtD
Trifluoperazine—Vision blurred—Capecitabine—colon cancer	0.000488	0.00314	CcSEcCtD
Trifluoperazine—Tremor—Capecitabine—colon cancer	0.000485	0.00313	CcSEcCtD
Trifluoperazine—Urticaria—Fluorouracil—colon cancer	0.00048	0.0031	CcSEcCtD
Trifluoperazine—Body temperature increased—Fluorouracil—colon cancer	0.000478	0.00308	CcSEcCtD
Trifluoperazine—Hypersensitivity—Vincristine—colon cancer	0.000477	0.00308	CcSEcCtD
Trifluoperazine—HRH1—lymph node—colon cancer	0.000477	0.00266	CbGeAlD
Trifluoperazine—Hypersensitivity—Irinotecan—colon cancer	0.000465	0.003	CcSEcCtD
Trifluoperazine—Asthenia—Vincristine—colon cancer	0.000465	0.003	CcSEcCtD
Trifluoperazine—Leukopenia—Capecitabine—colon cancer	0.000463	0.00299	CcSEcCtD
Trifluoperazine—ABCB1—lymphoid tissue—colon cancer	0.000463	0.00258	CbGeAlD
Trifluoperazine—Agranulocytosis—Methotrexate—colon cancer	0.00046	0.00297	CcSEcCtD
Trifluoperazine—ABCB1—digestive system—colon cancer	0.000457	0.00255	CbGeAlD
Trifluoperazine—Asthenia—Irinotecan—colon cancer	0.000453	0.00292	CcSEcCtD
Trifluoperazine—Cough—Capecitabine—colon cancer	0.000451	0.00291	CcSEcCtD
Trifluoperazine—Hypersensitivity—Fluorouracil—colon cancer	0.000445	0.00287	CcSEcCtD
Trifluoperazine—Dry mouth—Capecitabine—colon cancer	0.000431	0.00278	CcSEcCtD
Trifluoperazine—Dizziness—Vincristine—colon cancer	0.000428	0.00276	CcSEcCtD
Trifluoperazine—Pruritus—Fluorouracil—colon cancer	0.000428	0.00276	CcSEcCtD
Trifluoperazine—ABCB1—bone marrow—colon cancer	0.000421	0.00235	CbGeAlD
Trifluoperazine—Dizziness—Irinotecan—colon cancer	0.000417	0.00269	CcSEcCtD
Trifluoperazine—Skin disorder—Capecitabine—colon cancer	0.00041	0.00265	CcSEcCtD
Trifluoperazine—Rash—Vincristine—colon cancer	0.000408	0.00263	CcSEcCtD
Trifluoperazine—Dermatitis—Vincristine—colon cancer	0.000408	0.00263	CcSEcCtD
Trifluoperazine—Headache—Vincristine—colon cancer	0.000406	0.00262	CcSEcCtD
Trifluoperazine—ABCB1—vagina—colon cancer	0.000404	0.00225	CbGeAlD
Trifluoperazine—Anorexia—Capecitabine—colon cancer	0.000402	0.0026	CcSEcCtD
Trifluoperazine—Dizziness—Fluorouracil—colon cancer	0.0004	0.00258	CcSEcCtD
Trifluoperazine—Rash—Irinotecan—colon cancer	0.000398	0.00257	CcSEcCtD
Trifluoperazine—Dermatitis—Irinotecan—colon cancer	0.000397	0.00256	CcSEcCtD
Trifluoperazine—Headache—Irinotecan—colon cancer	0.000395	0.00255	CcSEcCtD
Trifluoperazine—Hypotension—Capecitabine—colon cancer	0.000395	0.00254	CcSEcCtD
Trifluoperazine—Erythema—Methotrexate—colon cancer	0.000385	0.00248	CcSEcCtD
Trifluoperazine—Nausea—Vincristine—colon cancer	0.000385	0.00248	CcSEcCtD
Trifluoperazine—Insomnia—Capecitabine—colon cancer	0.000382	0.00246	CcSEcCtD
Trifluoperazine—Rash—Fluorouracil—colon cancer	0.000381	0.00246	CcSEcCtD
Trifluoperazine—Dermatitis—Fluorouracil—colon cancer	0.000381	0.00246	CcSEcCtD
Trifluoperazine—Headache—Fluorouracil—colon cancer	0.000379	0.00244	CcSEcCtD
Trifluoperazine—Dyspnoea—Capecitabine—colon cancer	0.000376	0.00243	CcSEcCtD
Trifluoperazine—Nausea—Irinotecan—colon cancer	0.000375	0.00242	CcSEcCtD
Trifluoperazine—Nefazodone—ABCB1—colon cancer	0.000373	0.0816	CrCbGaD
Trifluoperazine—Decreased appetite—Capecitabine—colon cancer	0.000367	0.00237	CcSEcCtD
Trifluoperazine—Fatigue—Capecitabine—colon cancer	0.000364	0.00235	CcSEcCtD
Trifluoperazine—Triflupromazine—ABCB1—colon cancer	0.000363	0.0795	CrCbGaD
Trifluoperazine—Vision blurred—Methotrexate—colon cancer	0.000363	0.00234	CcSEcCtD
Trifluoperazine—Constipation—Capecitabine—colon cancer	0.000361	0.00233	CcSEcCtD
Trifluoperazine—Nausea—Fluorouracil—colon cancer	0.000359	0.00231	CcSEcCtD
Trifluoperazine—Leukopenia—Methotrexate—colon cancer	0.000345	0.00222	CcSEcCtD
Trifluoperazine—Trazodone—ABCB1—colon cancer	0.000345	0.0755	CrCbGaD
Trifluoperazine—ABCB1—liver—colon cancer	0.00034	0.0019	CbGeAlD
Trifluoperazine—Cough—Methotrexate—colon cancer	0.000336	0.00217	CcSEcCtD
Trifluoperazine—Urticaria—Capecitabine—colon cancer	0.000335	0.00216	CcSEcCtD
Trifluoperazine—Body temperature increased—Capecitabine—colon cancer	0.000334	0.00215	CcSEcCtD
Trifluoperazine—Convulsion—Methotrexate—colon cancer	0.000334	0.00215	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Methotrexate—colon cancer	0.000314	0.00203	CcSEcCtD
Trifluoperazine—Hypersensitivity—Capecitabine—colon cancer	0.000311	0.00201	CcSEcCtD
Trifluoperazine—Skin disorder—Methotrexate—colon cancer	0.000305	0.00197	CcSEcCtD
Trifluoperazine—Asthenia—Capecitabine—colon cancer	0.000303	0.00195	CcSEcCtD
Trifluoperazine—Anorexia—Methotrexate—colon cancer	0.0003	0.00193	CcSEcCtD
Trifluoperazine—Pruritus—Capecitabine—colon cancer	0.000299	0.00193	CcSEcCtD
Trifluoperazine—Hypotension—Methotrexate—colon cancer	0.000294	0.00189	CcSEcCtD
Trifluoperazine—Insomnia—Methotrexate—colon cancer	0.000284	0.00183	CcSEcCtD
Trifluoperazine—Dyspnoea—Methotrexate—colon cancer	0.00028	0.00181	CcSEcCtD
Trifluoperazine—Somnolence—Methotrexate—colon cancer	0.000279	0.0018	CcSEcCtD
Trifluoperazine—Dizziness—Capecitabine—colon cancer	0.000279	0.0018	CcSEcCtD
Trifluoperazine—Fluphenazine—ABCB1—colon cancer	0.000279	0.0611	CrCbGaD
Trifluoperazine—Decreased appetite—Methotrexate—colon cancer	0.000273	0.00176	CcSEcCtD
Trifluoperazine—Fatigue—Methotrexate—colon cancer	0.000271	0.00175	CcSEcCtD
Trifluoperazine—Rash—Capecitabine—colon cancer	0.000266	0.00172	CcSEcCtD
Trifluoperazine—Dermatitis—Capecitabine—colon cancer	0.000266	0.00172	CcSEcCtD
Trifluoperazine—Headache—Capecitabine—colon cancer	0.000265	0.00171	CcSEcCtD
Trifluoperazine—ABCB1—lymph node—colon cancer	0.000261	0.00146	CbGeAlD
Trifluoperazine—Clomipramine—ABCB1—colon cancer	0.000255	0.0559	CrCbGaD
Trifluoperazine—Nausea—Capecitabine—colon cancer	0.000251	0.00162	CcSEcCtD
Trifluoperazine—Urticaria—Methotrexate—colon cancer	0.00025	0.00161	CcSEcCtD
Trifluoperazine—Body temperature increased—Methotrexate—colon cancer	0.000248	0.0016	CcSEcCtD
Trifluoperazine—Hypersensitivity—Methotrexate—colon cancer	0.000232	0.00149	CcSEcCtD
Trifluoperazine—Promethazine—ABCB1—colon cancer	0.000226	0.0495	CrCbGaD
Trifluoperazine—Asthenia—Methotrexate—colon cancer	0.000226	0.00145	CcSEcCtD
Trifluoperazine—Pruritus—Methotrexate—colon cancer	0.000222	0.00143	CcSEcCtD
Trifluoperazine—Quetiapine—ABCB1—colon cancer	0.000216	0.0474	CrCbGaD
Trifluoperazine—Dizziness—Methotrexate—colon cancer	0.000208	0.00134	CcSEcCtD
Trifluoperazine—Rash—Methotrexate—colon cancer	0.000198	0.00128	CcSEcCtD
Trifluoperazine—Dermatitis—Methotrexate—colon cancer	0.000198	0.00128	CcSEcCtD
Trifluoperazine—Headache—Methotrexate—colon cancer	0.000197	0.00127	CcSEcCtD
Trifluoperazine—Nausea—Methotrexate—colon cancer	0.000187	0.0012	CcSEcCtD
Trifluoperazine—Clozapine—ABCB1—colon cancer	0.000186	0.0408	CrCbGaD
Trifluoperazine—Chlorpromazine—ABCB1—colon cancer	0.000175	0.0384	CrCbGaD
Trifluoperazine—CALM1—Signaling by GPCR—EGFR—colon cancer	1.19e-05	9.73e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—EGFR—colon cancer	1.19e-05	9.73e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—HRAS—colon cancer	1.19e-05	9.73e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EP300—colon cancer	1.19e-05	9.72e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—PIK3CA—colon cancer	1.19e-05	9.72e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—HRAS—colon cancer	1.19e-05	9.71e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PTGS2—colon cancer	1.19e-05	9.7e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PTGS2—colon cancer	1.19e-05	9.7e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—SRC—colon cancer	1.19e-05	9.68e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EP300—colon cancer	1.19e-05	9.67e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PPARG—colon cancer	1.18e-05	9.66e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EP300—colon cancer	1.18e-05	9.63e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EP300—colon cancer	1.18e-05	9.63e-05	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—AKT1—colon cancer	1.18e-05	9.62e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—HRAS—colon cancer	1.17e-05	9.56e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—HRAS—colon cancer	1.17e-05	9.53e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CASP3—colon cancer	1.17e-05	9.53e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—KRAS—colon cancer	1.17e-05	9.51e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—AKT1—colon cancer	1.16e-05	9.46e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—SRC—colon cancer	1.16e-05	9.46e-05	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—AKT1—colon cancer	1.16e-05	9.44e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—SRC—colon cancer	1.15e-05	9.41e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TP53—colon cancer	1.15e-05	9.4e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CASP3—colon cancer	1.15e-05	9.38e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—SRC—colon cancer	1.15e-05	9.37e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—SRC—colon cancer	1.15e-05	9.37e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CASP3—colon cancer	1.15e-05	9.36e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—NRAS—colon cancer	1.14e-05	9.32e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—AKT1—colon cancer	1.14e-05	9.29e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCND1—colon cancer	1.14e-05	9.28e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—AKT1—colon cancer	1.14e-05	9.27e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—VEGFA—colon cancer	1.13e-05	9.21e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CASP3—colon cancer	1.13e-05	9.21e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—KRAS—colon cancer	1.13e-05	9.19e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—KRAS—colon cancer	1.13e-05	9.19e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—EGFR—colon cancer	1.13e-05	9.19e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CTNNB1—colon cancer	1.13e-05	9.19e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CASP3—colon cancer	1.13e-05	9.18e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—VEGFA—colon cancer	1.12e-05	9.16e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCND1—colon cancer	1.12e-05	9.13e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCND1—colon cancer	1.12e-05	9.11e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—NRAS—colon cancer	1.12e-05	9.1e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—NRAS—colon cancer	1.11e-05	9.05e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CTNNB1—colon cancer	1.11e-05	9.04e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CTNNB1—colon cancer	1.11e-05	9.02e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—NRAS—colon cancer	1.11e-05	9.01e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—NRAS—colon cancer	1.11e-05	9.01e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—HRAS—colon cancer	1.1e-05	8.99e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CDKN1A—colon cancer	1.1e-05	8.97e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCND1—colon cancer	1.1e-05	8.96e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCND1—colon cancer	1.1e-05	8.94e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—EGFR—colon cancer	1.09e-05	8.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—EGFR—colon cancer	1.09e-05	8.89e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CTNNB1—colon cancer	1.09e-05	8.87e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CTNNB1—colon cancer	1.09e-05	8.85e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CDKN1A—colon cancer	1.08e-05	8.83e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CDKN1A—colon cancer	1.08e-05	8.81e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—AKT1—colon cancer	1.07e-05	8.73e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—PIK3CA—colon cancer	1.07e-05	8.73e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—KRAS—colon cancer	1.07e-05	8.68e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—MYC—colon cancer	1.06e-05	8.68e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CDKN1A—colon cancer	1.06e-05	8.67e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—TGFB1—colon cancer	1.06e-05	8.66e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CDKN1A—colon cancer	1.06e-05	8.64e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—AKT1—colon cancer	1.05e-05	8.59e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—AKT1—colon cancer	1.05e-05	8.58e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EP300—colon cancer	1.05e-05	8.54e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—EGFR—colon cancer	1.04e-05	8.49e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—MYC—colon cancer	1.04e-05	8.47e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TGFB1—colon cancer	1.04e-05	8.45e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—PIK3CA—colon cancer	1.04e-05	8.45e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—PIK3CA—colon cancer	1.04e-05	8.45e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—AKT1—colon cancer	1.03e-05	8.44e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—MYC—colon cancer	1.03e-05	8.43e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—AKT1—colon cancer	1.03e-05	8.41e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TGFB1—colon cancer	1.03e-05	8.41e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—KRAS—colon cancer	1.03e-05	8.4e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—KRAS—colon cancer	1.03e-05	8.4e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EP300—colon cancer	1.03e-05	8.4e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—MYC—colon cancer	1.03e-05	8.39e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—MYC—colon cancer	1.03e-05	8.39e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EP300—colon cancer	1.03e-05	8.38e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.03e-05	8.38e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—TGFB1—colon cancer	1.03e-05	8.37e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—TGFB1—colon cancer	1.03e-05	8.37e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—EP300—colon cancer	1.02e-05	8.34e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—SRC—colon cancer	1.02e-05	8.3e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—EGFR—colon cancer	1.02e-05	8.29e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EP300—colon cancer	1.01e-05	8.25e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—EGFR—colon cancer	1.01e-05	8.25e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EP300—colon cancer	1.01e-05	8.23e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—EGFR—colon cancer	1.01e-05	8.21e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—EGFR—colon cancer	1.01e-05	8.21e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—SRC—colon cancer	1e-05	8.17e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—SRC—colon cancer	1e-05	8.15e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—VEGFA—colon cancer	9.92e-06	8.09e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—HRAS—colon cancer	9.91e-06	8.08e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—EP300—colon cancer	9.9e-06	8.07e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—EP300—colon cancer	9.9e-06	8.07e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—SRC—colon cancer	9.84e-06	8.02e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—KRAS—colon cancer	9.83e-06	8.02e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—SRC—colon cancer	9.81e-06	8e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—NRAS—colon cancer	9.8e-06	7.99e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—PIK3CA—colon cancer	9.79e-06	7.98e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—VEGFA—colon cancer	9.76e-06	7.96e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—VEGFA—colon cancer	9.74e-06	7.94e-05	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKT1—colon cancer	9.74e-06	7.94e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—NRAS—colon cancer	9.64e-06	7.86e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—NRAS—colon cancer	9.62e-06	7.84e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—KRAS—colon cancer	9.6e-06	7.83e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—HRAS—colon cancer	9.59e-06	7.82e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—HRAS—colon cancer	9.59e-06	7.82e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—VEGFA—colon cancer	9.58e-06	7.81e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—VEGFA—colon cancer	9.56e-06	7.79e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—KRAS—colon cancer	9.55e-06	7.79e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CASP3—colon cancer	9.55e-06	7.78e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—KRAS—colon cancer	9.51e-06	7.76e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—KRAS—colon cancer	9.51e-06	7.76e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—PIK3CA—colon cancer	9.47e-06	7.72e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—PIK3CA—colon cancer	9.47e-06	7.72e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—NRAS—colon cancer	9.46e-06	7.72e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PPARG—colon cancer	9.46e-06	7.71e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—NRAS—colon cancer	9.44e-06	7.7e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PTGS2—colon cancer	9.32e-06	7.6e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCND1—colon cancer	9.29e-06	7.58e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CASP3—colon cancer	9.23e-06	7.53e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CASP3—colon cancer	9.23e-06	7.53e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CTNNB1—colon cancer	9.2e-06	7.5e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—MYC—colon cancer	9.13e-06	7.44e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TGFB1—colon cancer	9.1e-06	7.42e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HRAS—colon cancer	9.05e-06	7.38e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—PIK3CA—colon cancer	9.04e-06	7.37e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CDKN1A—colon cancer	8.99e-06	7.33e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCND1—colon cancer	8.99e-06	7.33e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCND1—colon cancer	8.99e-06	7.33e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—MYC—colon cancer	8.98e-06	7.32e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—MYC—colon cancer	8.96e-06	7.3e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TGFB1—colon cancer	8.96e-06	7.3e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TGFB1—colon cancer	8.94e-06	7.29e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—EGFR—colon cancer	8.93e-06	7.28e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CTNNB1—colon cancer	8.9e-06	7.26e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CTNNB1—colon cancer	8.9e-06	7.26e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—PIK3CA—colon cancer	8.82e-06	7.19e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—MYC—colon cancer	8.82e-06	7.19e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TGFB1—colon cancer	8.79e-06	7.17e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—MYC—colon cancer	8.79e-06	7.17e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—EGFR—colon cancer	8.78e-06	7.16e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—PIK3CA—colon cancer	8.78e-06	7.16e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TGFB1—colon cancer	8.77e-06	7.15e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—EGFR—colon cancer	8.76e-06	7.14e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HRAS—colon cancer	8.76e-06	7.14e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HRAS—colon cancer	8.76e-06	7.14e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—AKT1—colon cancer	8.75e-06	7.13e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—PIK3CA—colon cancer	8.74e-06	7.13e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—PIK3CA—colon cancer	8.74e-06	7.13e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CDKN1A—colon cancer	8.7e-06	7.09e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CDKN1A—colon cancer	8.7e-06	7.09e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—EGFR—colon cancer	8.62e-06	7.03e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—EGFR—colon cancer	8.6e-06	7.01e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EP300—colon cancer	8.55e-06	6.97e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TP53—colon cancer	8.54e-06	6.96e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TP53—colon cancer	8.49e-06	6.92e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—AKT1—colon cancer	8.46e-06	6.9e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—AKT1—colon cancer	8.46e-06	6.9e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—KRAS—colon cancer	8.43e-06	6.87e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—HRAS—colon cancer	8.36e-06	6.82e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—SRC—colon cancer	8.32e-06	6.78e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—KRAS—colon cancer	8.3e-06	6.76e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—KRAS—colon cancer	8.28e-06	6.75e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EP300—colon cancer	8.27e-06	6.75e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EP300—colon cancer	8.27e-06	6.75e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—HRAS—colon cancer	8.16e-06	6.66e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—KRAS—colon cancer	8.15e-06	6.64e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—KRAS—colon cancer	8.12e-06	6.62e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—HRAS—colon cancer	8.12e-06	6.62e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—VEGFA—colon cancer	8.1e-06	6.6e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—HRAS—colon cancer	8.09e-06	6.59e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—HRAS—colon cancer	8.09e-06	6.59e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—SRC—colon cancer	8.05e-06	6.56e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—SRC—colon cancer	8.05e-06	6.56e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—NRAS—colon cancer	8e-06	6.52e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—AKT1—colon cancer	7.99e-06	6.52e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—VEGFA—colon cancer	7.84e-06	6.39e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—VEGFA—colon cancer	7.84e-06	6.39e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—EP300—colon cancer	7.75e-06	6.32e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—PIK3CA—colon cancer	7.75e-06	6.32e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—NRAS—colon cancer	7.74e-06	6.31e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—NRAS—colon cancer	7.74e-06	6.31e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—AKT1—colon cancer	7.73e-06	6.31e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—AKT1—colon cancer	7.73e-06	6.31e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—PIK3CA—colon cancer	7.62e-06	6.21e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—PIK3CA—colon cancer	7.61e-06	6.2e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—PIK3CA—colon cancer	7.57e-06	6.17e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TP53—colon cancer	7.49e-06	6.11e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—PIK3CA—colon cancer	7.48e-06	6.1e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—PIK3CA—colon cancer	7.46e-06	6.08e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—MYC—colon cancer	7.45e-06	6.08e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PTGS2—colon cancer	7.44e-06	6.07e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TGFB1—colon cancer	7.44e-06	6.06e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKT1—colon cancer	7.38e-06	6.02e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TP53—colon cancer	7.37e-06	6.01e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TP53—colon cancer	7.36e-06	6e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—PIK3CA—colon cancer	7.32e-06	5.97e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—PIK3CA—colon cancer	7.32e-06	5.97e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—EGFR—colon cancer	7.29e-06	5.94e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TP53—colon cancer	7.24e-06	5.9e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TP53—colon cancer	7.22e-06	5.89e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—MYC—colon cancer	7.21e-06	5.88e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—MYC—colon cancer	7.21e-06	5.88e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKT1—colon cancer	7.21e-06	5.88e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TGFB1—colon cancer	7.19e-06	5.86e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TGFB1—colon cancer	7.19e-06	5.86e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKT1—colon cancer	7.17e-06	5.85e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—HRAS—colon cancer	7.17e-06	5.84e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKT1—colon cancer	7.14e-06	5.82e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKT1—colon cancer	7.14e-06	5.82e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—EGFR—colon cancer	7.05e-06	5.75e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—EGFR—colon cancer	7.05e-06	5.75e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—HRAS—colon cancer	7.05e-06	5.75e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—HRAS—colon cancer	7.04e-06	5.74e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—HRAS—colon cancer	6.92e-06	5.65e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—HRAS—colon cancer	6.91e-06	5.63e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—KRAS—colon cancer	6.89e-06	5.61e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—KRAS—colon cancer	6.66e-06	5.43e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—KRAS—colon cancer	6.66e-06	5.43e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKT1—colon cancer	6.33e-06	5.16e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—PIK3CA—colon cancer	6.33e-06	5.16e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKT1—colon cancer	6.23e-06	5.08e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKT1—colon cancer	6.21e-06	5.07e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—EP300—colon cancer	6.19e-06	5.05e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—AKT1—colon cancer	6.18e-06	5.04e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TP53—colon cancer	6.12e-06	4.99e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—PIK3CA—colon cancer	6.12e-06	4.99e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—PIK3CA—colon cancer	6.12e-06	4.99e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKT1—colon cancer	6.11e-06	4.98e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKT1—colon cancer	6.1e-06	4.97e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—AKT1—colon cancer	5.98e-06	4.88e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—AKT1—colon cancer	5.98e-06	4.88e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TP53—colon cancer	5.92e-06	4.83e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TP53—colon cancer	5.92e-06	4.83e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—HRAS—colon cancer	5.85e-06	4.77e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—PIK3CA—colon cancer	5.73e-06	4.68e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—HRAS—colon cancer	5.66e-06	4.62e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—HRAS—colon cancer	5.66e-06	4.62e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKT1—colon cancer	5.17e-06	4.21e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKT1—colon cancer	5e-06	4.08e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKT1—colon cancer	5e-06	4.08e-05	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—AKT1—colon cancer	4.68e-06	3.82e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—PIK3CA—colon cancer	4.58e-06	3.73e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—AKT1—colon cancer	3.74e-06	3.05e-05	CbGpPWpGaD
